Subject(s)
Edema/parasitology , Leishmaniasis, Mucocutaneous/diagnosis , Lip Diseases/parasitology , Amphotericin B/therapeutic use , Antiprotozoal Agents/therapeutic use , Chronic Disease , Edema/pathology , Humans , Leishmaniasis, Mucocutaneous/drug therapy , Leishmaniasis, Mucocutaneous/pathology , Lip Diseases/drug therapy , Lip Diseases/pathology , Male , Middle AgedSubject(s)
Botulinum Toxins, Type A/therapeutic use , Ischemia/drug therapy , Neuromuscular Agents/therapeutic use , Raynaud Disease/complications , Scleroderma, Systemic/complications , Toes/blood supply , Ulcer/drug therapy , Adult , Female , Humans , Ischemia/etiology , Treatment Outcome , Ulcer/etiologyABSTRACT
No disponible
Subject(s)
Humans , Male , Young Adult , Patch Tests/adverse effects , Eosinophilia/chemically induced , Drug Hypersensitivity/complications , Drug-Related Side Effects and Adverse Reactions/complications , RecurrenceSubject(s)
Drug Hypersensitivity Syndrome/etiology , Patch Tests/adverse effects , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects , Cyclosporine/therapeutic use , Drug Hypersensitivity Syndrome/drug therapy , Humans , Male , Prednisone/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Young AdultABSTRACT
BACKGROUND: Information regarding the use intravenous catheters (IVC) in conventional hospital units and its consequence in terms of intravenous catéter-related bacteremia (ICRB) is scarce. OBJECTIVES: To evaluate the use of IVC in patients admitted in conventional wards of a general hospital and to measure IVCRB incidence in such patients. METHODS: We evaluated during one week IVC use in adult patients admitted in 12 de Octubre Hospital and we calculated la incidence density of ICRB. RESULTS: We evaluated the clinical charts of 731 patients (284 from medical wards and 447 from surgical wards), of which 338 (46.2%) had a peripheral VC inserted and 63 (8.6%) a central IVC. Central IVC had been inserted for a mean time 11.5 days globally (CI 95% 5.57-17.42), being 28.3 in medical wards and 8.32 days in surgical wards (p = 0.2). In 27.7 % of the patients with IVC intravenous antimicrobials was the only reason for the use of such catheters in spite of adequate oral tolerance in 30 % of the patients with central IVC an specific note explaining the reason for implanting such catheter was lacking in the clinical chart. IVCRB was detected in 12/401 patients (3%). The incidence density of IVCRB in central IVC was 8.28 per 1000 catheter-days. CONCLUSIONS: There are some aspects that could be clearly improved regarding the prevention of IVCRB, mostly in the indications, the excess of time those catheters are kept implanted and in the lost chances for catheter withdrawal when switch-therapy could be performed.
Subject(s)
Bacteremia/epidemiology , Catheters, Indwelling/statistics & numerical data , Cross Infection/epidemiology , Hospitals/statistics & numerical data , Unnecessary Procedures/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Catheterization, Central Venous/statistics & numerical data , Catheterization, Peripheral/statistics & numerical data , Humans , Middle Aged , Prosthesis-Related Infections/epidemiology , RiskABSTRACT
Antecedentes: Existe escasa información acerca del uso de catéteres venosos (CVs) en unidades de hospitalización convencionales y la incidencia bacteriemia relacionada con catéteres venosos (BRCV) en dichas unidades. Objetivos: Evaluar el uso de catéteres venosos (CVs) en pacientes ingresados en plantas convencionales de un hospital general y las consecuencias en términos de BRCV. Métodos: Se evaluó durante una semana el uso de catéteres venosos y la densidad de incidencia de BRCV en pacientes adultos ingresados en los servicios de hospitalización del hospital 12 de Octubre de Madrid. Resultados: Se analizaron las historias clínicas de 731 pacientes (284 en servicios médicos y 447 en servicios quirúrgicos), de los cuales 338 (46,2%) eran portadores en ese momento de un CV periférico y 63 (8,6%) de un CV central. La media de días de colocación de un CV central fue globalmente de 11,5 (IC 95% 5,57-17,42), 28,3 en los servicios médicos días y 8,32 en los servicios quirúrgicos (p = 0,2). En el 27,7% de los pacientes con CVs la única indicación para el uso de un CV fue la administración intravenosa de antibióticos a pesar de que el paciente toleraba por vía oral y en un 30% de las ocasiones no había ninguna especificación en la historia que permitiera aclarar cuál era la indicación para la colocación del CV. Se detectó BRCV en 12/401 pacientes (3%). La densidad de incidencia de BRC en CV centrales fue de 8,28 por cada 1.000 días de catéter. Conclusiones: Existen claros aspectos que deben mejorarse en cuanto a la prevención de la BRC, fundamentalmente respecto al ajuste de las indicaciones, el tiempo que permanecen los catéteres centrales implantados y, sobre todo, en cuanto a las oportunidades perdidas de retirar el catéter secuenciando la medicación a vía oral
Background: Information regarding the use intravenous catheters (IVC) in conventional hospital units and its consequence in terms of intravenous catéter-related bacteremia (ICRB) is scarce. Objectives: To evaluate the use of IVC in patients admitted in conventional wards of a general hospital and to measure IVCRB incidence in such patients. Methods: We evaluated during one week IVC use in adult patients admitted in 12 de Octubre Hospital and we calculated la incidence densitity of ICRB. Results: We evaluated the clinical charts of 731 patients (284 from medical wards and 447 from surgical wards), of which 338 (46.2%) had a peripheral VC inserted and 63 (8.6%) a central IVC. Central IVC had been inserted for a mean time 11.5 days globally (CI 95% 5.57-17.42), being 28.3 in medical wards and 8.32 days in surgical wards (p=0.2). In 27.7 % of the patients with IVC intravenous antimicrobials was the only reason for the use of such catheters in spite of adequate oral tolerance in 30 % of the patients with central IVC an specific note explaining the reason for implanting such catheter was lacking in the clinical chart. IVCRB was detected in 12/401 patients (3%). The incidence density of IVCRB in central IVC was 8.28 per 1000 catheter-days. Conclusions: There are some aspects that could be clearly improved regarding the prevention of IVCRB, mostly in the indications, the excess of time those catheters are kept implanted and in the lost chances for catheter withdrawal when switch-therapy could be performed